Alert: Chemidex steroid products

Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information.

Cartons for the products/batches listed are missing side effect information related to visual disturbances.

The alert also concerns batches expected to be distributed from May 2025.

Healthcare professionals are advised to take this into account when prescribing these products. Affected products are not being recalled.

MHRA alert

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

Alert: Chemidex steroid products

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association